| Acceptance rate | 46% |
|---|---|
| Time to first decision | 20 days* |
| Time to decision with review | 50 days* |
*Approximate number of days
**The days mentioned above are averages and do not indicate exact durations. The process may vary for each article.
ACTA Pharmaceutica Sciencia
2024 , Vol 62 , Num 2
Efficacy of statin therapy on achieving target goal of LDL among Iraqi patients
1 Kut University College, School of Pharmacy, Department of Clinical Pharmacy, Alkut, Wasit, Iraq2 Al-Yarmouk University College, School of Pharmacy, Department of Clinical Pharmacy Baqubah/Diyala, Iraq
DOI : 10.23893/1307-2080.APS6218 Dietary and statin treatment planning are central to the management of dyslipidemia. The treatment"s efficacy is determined by how well it achieves the level of low-density lipoprotein (LDL)- target goal established by European guidelines for that reason the target (LDL) in patients receiving different types and doses of statin therapy were evaluated in this prospective, cross-sectional study was conducted on patients recruited from Al Karama Teaching Hospital, Kut, Iraq to assess the levels of serum LDL in addition to data collected directly from the patients included demographic characteristics, BMI, and types, doses, and duration of statins used which showed that target goal (optimal) was achieved in 82.4% in patients taking statin. The LDL-target goal was achieved in 85.4% of patients taking statin with moderate risk, in 82.6% with high risk, and 80.6 % with very high risk which indicate that the targeted LDL levels were achieved in good proportion in patients with high and moderate risk of dyslipidemia with a less extent proportion in patients with very high-risk of dyslipidemia. It was also demonstrated that the LDL target levels were achieved more efficiently with a higher dose of statins. Keywords : cardiovascular diseases, dyslipidemia, statin target goal